03:41 PM EST, 12/03/2024 (MT Newswires) -- Health care stocks were mixed in late Tuesday afternoon trading with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) marginally lower.

The iShares Biotechnology ETF (IBB) fell 1.1%.

In corporate news, Revelation Biosciences ( REVB ) stock plunged 43% after the company signed an agreement for the immediate exercise of some outstanding warrants to buy up to about 4.1 million shares at an exercise price of $1 apiece.

Cytokinetics ( CYTK ) shares added 1.2% after the company said Tuesday it's enrolling patients in a phase 3 trial designed to evaluate the efficacy and safety of omecamtiv mecarbil in people with symptomatic heart failure with severely reduced ejection fraction.

Janux Therapeutics ( JANX ) shares surged 49%. The company reported late Monday positive interim clinical data for its JANX007 clinical program in prostate cancer patients.

Rezolute ( RZLT ) shares rose 5.7% after the company said Tuesday the US Food and Drug Administration granted orphan drug designation to ersodetug to treat hypoglycemia caused by tumor hyperinsulinism.